Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
3
×
glaxosmithkline
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
clinical study
commissioner
crispr
crispr-cas9
democrats
eli lilly
failure
gene editing
indiana blog main
indiana top stories
ipo
messenger rna
What
bio
crispr
3
×
roundup
3
×
alliance
allogene
big
bosley's
bosley’s
bridge
bristol
bucks
buy
calls
cancer
cas
ceo
changing
color
crime
days
departure
diversity
editas
exit
growing
guiding
hot
hours
immunotherapy
investors
ipo
juno
katrine
kudos
leaves
medicine
million
moves
myers’s
nearly
Language
unset
Current search:
fda
×
roundup
×
biotech
×
crispr
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More